Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 611
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02403193 | Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | ||
| NCT05581030 | CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) | ||
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | ||
| NCT05751941 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer | ||
| NCT06519097 | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) | ||
| NCT03655756 | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma | ||
| NCT07487168 | Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT02981797 | Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT03870399 | Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | ||
| NCT01672944 | Evaluating Biobanking Educational Tools | ||
| NCT01008527 | Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | ||
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | ||
| NCT06909357 | Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients | ||
| NCT01496807 | Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma | ||
| NCT00598507 | Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma | ||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT05645146 | Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) | ||
| NCT02776709 | Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass) | ||
| NCT00042731 | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | ||
| NCT00006085 | CP-609,754 in Treating Patients With Advanced Solid Tumors | ||
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) | ||
| NCT00985777 | Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia | ||
| NCT05694364 | Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies | ||
| NCT03043599 | Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer | ||
| NCT04588545 | Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease | ||
| NCT00387647 | Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy | ||
| NCT04879940 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | ||
| NCT00215982 | Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | ||
| NCT07725380 | Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma | ||
| NCT02638090 | Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) | ||
| NCT02155088 | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer | ||
| NCT03712943 | Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer | ||
| NCT04975152 | Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma | ||
| NCT03614949 | SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | ||
| NCT02440425 | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer | ||
| NCT05438940 | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients | ||
| NCT00601796 | Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer | ||
| NCT01599520 | Stress Management Training for Latinas Receiving Chemotherapy | ||
| NCT01090973 | Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) | ||
| NCT05651828 | Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma | ||
| NCT04091165 | Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery | ||
| NCT00738751 | Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers | ||
| NCT00365872 | External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | ||
| NCT00365222 | Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma | ||
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | ||
| NCT00496340 | Phase II Trial of Pentostatin and Targeted Busulfan | ||
| NCT00751140 | Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection | ||
| NCT01437605 | Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC |
